Objective
A leading pharma company engaged WNS to conduct competitor analysis and monitoring for osteoporosis market.
Geography: G7.
Indication: Osteoporosis in women and men
Approach
WNS provided complete CI Monitoring support in osteoporosis space through daily Newsletters, periodic reports and responding to ad-hoc requests, thereby generating significant insights for the client to bolster its clinical development program.
Project Illustrations
Business Impact
Through on-going comprehensive CI tracking in Osteoporosis domain, client was able to keep abreast of the competitor strategies and formulate counter strategies.
Regular CI update was effective in keeping an eye on other developments in the indication ranging from target population and evolving market dynamics
